Search

Your search keyword '"Patient monitoring equipment -- Evaluation"' showing total 68 results
Start Over Descriptor "Patient monitoring equipment -- Evaluation"
68 results on '"Patient monitoring equipment -- Evaluation"'

1. New Hematology Findings Has Been Reported by Investigators at Department of Biomedical Engineering (Tuning the Localized Microenvironment Near a Continuous Glucose Meter To Ensure Monitoring Accuracy and Longevity By Plasma-induced Grafting ...)

Subjects
Patient monitoring equipment -- Evaluation, Blood sugar -- Reports -- Research, Blood sugar monitoring -- Reports -- Research, Biomedical engineering -- Research -- Reports, Physical fitness -- Research -- Reports
Abstract

2025 JAN 4 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Hematology. According to news reporting out of [...]

Published
2025

2. Research on Bone Marrow Cancer Discussed by a Researcher at Mustansiriyah University (Evaluating the Impact of Lenalidomide on Bone Marrow Cancer Treatment: Monitoring White Blood Cell, Hemoglobin, and Platelet Levels)

Subjects
Oncology, Experimental, Hemoglobin, Cancer -- Care and treatment -- Research, Patient monitoring equipment -- Evaluation, Multiple myeloma -- Drug therapy, Health
Abstract

2025 JAN 3 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators discuss new findings in bone marrow cancer. According to news originating from [...]

Published
2025

8. Continuous Monitoring of Glucose and Oxygen using an Insertable Biomaterial-based Multianalyte Barcode Sensor

Subjects
Dextrose, Biological products -- Evaluation, Chronic diseases, Sensors -- Evaluation, Bar codes, Glucose, Patient monitoring equipment -- Evaluation, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

2024 AUG 7 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- According to news reporting based on a preprint abstract, our journalists obtained the following quote [...]

Published
2024

9. New Findings Reported from Mashhad University of Medical Sciences Describe Advances in Health and Medicine (Evaluating the Usability of a Medical Care Monitoring Center System Using Heuristic Method)

Subjects
Medical informatics -- Methods -- Analysis -- Reports, Patient monitoring equipment -- Evaluation, Business, Health, Health care industry
Abstract

2024 MAY 5 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- New research on agriculture is the subject of a new [...]

Published
2024

10. Investigators at Dexcom Inc. Report Findings in Blood Glucose Monitoring (Performance of the Dexcom G7 Continuous Glucose Monitoring System In Pregnant Women With Diabetes)

Subjects
DexCom Inc. -- Reports, Medical test kit industry -- Reports -- Analysis, Medical equipment and supplies industry -- Reports -- Analysis, Medical testing products -- Evaluation, Patient monitoring equipment -- Evaluation, Blood sugar -- Analysis -- Reports, Pregnant women -- Analysis -- Reports, Blood sugar monitoring -- Reports -- Analysis, Diabetics -- Analysis -- Reports, Health, Health care industry
Abstract

2024 APR 14 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Devices & Surgical Technology Week -- Research findings on Medical Devices - Blood Glucose Monitoring are discussed [...]

Published
2024

11. Researchers at University of British Columbia Target Opioids (Feeling safer: effectiveness, feasibility, and acceptability of continuous pulse oximetry for people who smoke opioids at overdose prevention services in British Columbia, Canada)

Subjects
Drugs -- Overdose, Opioids, Oximetry, Patient monitoring equipment -- Evaluation, Business, Health, Health care industry
Abstract

2024 MAR 24 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- Data detailed on opioids have been presented. According to news [...]

Published
2024

12. Research from University of Surrey in the Area of Digital Technology Described (A Protocol for Evaluating Digital Technology for Monitoring Sleep and Circadian Rhythms in Older People and People Living with Dementia in the Community)

Subjects
Aged, Mental health, Circadian rhythms, Patient monitoring equipment -- Evaluation, Gerontology, Health, Psychology and mental health, University of Surrey -- Evaluation
Abstract

2024 MAR 18 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- New research on digital technology is the subject of a new report. According [...]

Published
2024

13. Accuracy of the ClearSight[TM] system in patients undergoing abdominal aortic aneurysm surgery

Author

Sumiyoshi, Miho, Maeda, Takuma, Miyazaki, Erika, Hotta, Naoshi, Sato, Hitoshi, Hamaguchi, Eisuke, and Kanazawa, Hiroko

Subjects
Blood vessels -- Surgery, Abdominal aneurysm -- Analysis -- Care and treatment -- Patient outcomes, Patient monitoring equipment -- Evaluation, Health
Abstract

Purpose The ClearSight[TM] device monitors continuous pressure and cardiac output via pulse contour analysis. ClearSight[TM], however, may not be reliable in patients with reduced peripheral perfusion caused by high peripheral resistance. This study aimed to elucidate the accuracy and trending ability of ClearSight[TM] in patients undergoing abdominal aortic aneurysm (AAA) surgery by comparing the ClearSight.sup.TM-derived cardiac index (CI.sub.CS) with that measured using three-dimensional echocardiography (CI.sub.3D). Methods The study included 20 patients who underwent elective AAA surgery. CI.sub.CS and CI.sub.3D were measured simultaneously at eight time points during the surgery. Trending ability was investigated after aortic clamping and unclamping. We used CI.sub.3D as the reference method. Results Bland-Altman analysis showed a wide limit of agreement between CI.sub.CS and CI.sub.3D (percentage error 41.3%). Subgroup analysis showed a lower percentage error (33.2%) in patients with CI [greater than or equal to] 2.5 L/min/m.sup.2. The cubic splines related to the CI.sub.3D and CI discrepancy were negatively sloped, indicating that CI.sub.3D had significant influence on the CI discrepancy (p < 0.001). Four-quadrant plot analysis showed that the tracking ability of ClearSight[TM] after aortic clamping and declamping were clinically unacceptable (81.3% and 78.6%, respectively). Also, the polar plot analysis showed that the concordance rate of ClearSight[TM] after aortic clamping and declamping were clinically unacceptable (58.3% and 66.7%, respectively). Conclusions ClearSight[TM] was not sufficiently accurate in patients undergoing AAA surgery. The tracking ability of ClearSight[TM] after aortic clamping was below the acceptable limit., Author(s): Miho Sumiyoshi [sup.1] , Takuma Maeda [sup.2] [sup.3] , Erika Miyazaki [sup.2] , Naoshi Hotta [sup.2] , Hitoshi Sato [sup.2] , Eisuke Hamaguchi [sup.2] , Hiroko Kanazawa [sup.2] , [...]

Published
2019
Full Text
View/download PDF

14. Findings from Berlin Broaden Understanding of Neuroendocrine Cancer (Plasma Markers for Therapy Response Monitoring in Patients with Neuroendocrine Tumors Undergoing Peptide Receptor Radionuclide Therapy)

Subjects
Patient monitoring equipment -- Evaluation, Cancer -- Prognosis -- Care and treatment, Peptides -- Reports -- Research, Health
Abstract

2023 DEC 29 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Research findings on neuroendocrine cancer are discussed in a new report. According to [...]

Published
2023

15. A protocol for evaluating digital technology for monitoring sleep and circadian rhythms in older people and people living with dementia in the community

Subjects
Aged, Mental health, Circadian rhythms, Patient monitoring equipment -- Evaluation, Gerontology, Health, Psychology and mental health
Abstract

2023 NOV 27 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- According to news reporting based on a preprint abstract, our journalists obtained the [...]

Published
2023

16. Research on Neuromuscular Manifestations Published by a Researcher at University Hospital (Development of the Clinical Myotonia Rating Scale and a Mexiletine Prescribing and Monitoring Algorithm for Patients with Non-Dystrophic Myotonia)

Subjects
Mexiletine -- Evaluation -- Research, Prescription writing -- Research -- Reports, Patient monitoring equipment -- Evaluation, Algorithms -- Reports -- Research, Algorithm, Health
Abstract

2023 SEP 8 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators publish new report on neuromuscular manifestations. According to news reporting out of [...]

Published
2023

17. Remote patient monitoring fitness test

Subjects
Telemedicine -- Evaluation, Patient monitoring equipment -- Evaluation, Business, Economics, Health care industry
Abstract

Introduction: Interest in remote patient monitoring (RPM)--using digital technologies to track and capture patients' medical/health data and electronically transmitting it to their health care providers--has been growing for years. But [...]

Published
2021

18. Research from Universidad Autonoma de Madrid Reveals New Findings on Hypoglycemia (Mixed Meal Tolerance Test Versus Continuous Glucose Monitoring for an Effective Diagnosis of Persistent Post-Bariatric Hypoglycemia)

Subjects
Dextrose -- Research -- Reports, Patient monitoring equipment -- Evaluation, Glucose -- Research -- Reports, Blood sugar monitoring -- Reports -- Research, Health
Abstract

2023 JUL 21 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Fresh data on hypoglycemia are presented in a new report. According to news [...]

Published
2023

19. Moody's: Medtronic's planned spinoff of its patient monitoring and respiratory interventions businesses reduces business diversity

Subjects
Medtronic PLC -- Securities, Moody's Investors Service Inc. -- Securities, Holding companies, Medical test kit industry -- Securities, Medical equipment and supplies industry -- Securities, Patient monitoring equipment -- Evaluation, Company securities, Business, international
Abstract

New York City: Moody's Investors Service has issued the following news release: Moody's Investors Service ('Moody's') commented that the announcement by Medtronic, Inc. ('Medtronic') that it intends to separate its [...]

Published
2022

20. Findings from Arizona State University in the Area of COVID-19 Reported (Systematic Scoping Review Evaluating the Potential of Wastewater-based Epidemiology for Monitoring Cardiovascular Disease and Cancer)

Subjects
Wastewater -- Evaluation, Patient monitoring equipment -- Evaluation, Cancer -- Diagnosis, Cardiovascular diseases -- Diagnosis, Epidemiology -- Reports, Coronaviruses -- Reports, Business, Health, Health care industry, Arizona State University -- Reports -- Evaluation
Abstract

2023 FEB 14 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Investigators publish new report on Coronavirus - COVID-19. According to news originating from Tempe, Arizona, [...]

Published
2023

21. Reports from University of Zurich Describe Recent Advances in Clinical Neurophysiology (Evaluation of a New Cortical Strip Electrode for Intraoperative Somatosensory Monitoring During Perirolandic Brain Surgery)

Subjects
Nervous system -- Surgery, Patient monitoring equipment -- Evaluation, Neurophysiology, Health, University of Zurich -- Evaluation
Abstract

2022 OCT 28 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Data detailed on Health and Medicine - Clinical Neurophysiology have been presented. According [...]

Published
2022

22. Reports from University Hospital Virgen Rocio Provide New Insights into Type 1 Diabetes (Effectiveness and Safety of Insulin Glargine 300 U/ml In Comparison With Insulin Degludec 100 U/ml Evaluated With Continuous Glucose Monitoring In Adults ...)

Subjects
Dextrose -- Safety and security measures -- Analysis, Insulin glargine -- Evaluation, Type 1 diabetes -- Analysis -- Safety and security measures, Insulin -- Evaluation, Patient monitoring equipment -- Evaluation, Glucose -- Safety and security measures -- Analysis, Adults -- Safety and security measures -- Analysis, Blood sugar monitoring -- Analysis -- Safety and security measures, Health
Abstract

2022 SEP 19 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Trials Week -- Data detailed on Nutritional and Metabolic Diseases and Conditions - Type 1 Diabetes have [...]

Published
2022

23. Development of a routine outcome monitoring instrument for use with clients in the New Zealand alcohol and other drug treatment. sector: the Alcohol and Drug Outcome Measure (ADOM)

Author

Pulford, Justin, Deering, Daryle E., Robinson, Gail, Wheeler, Amanda, Adamson, Simon J., Frampton, Christopher M.A., Dunbar, Lucy, and Paton-Simpson, Grant

Subjects
Drug abuse -- Care and treatment, Treatment outcome -- Equipment and supplies, Alcoholism -- Care and treatment, Patient monitoring equipment -- Evaluation, Psychology and mental health
Abstract

This paper describes the development and evaluation of the Alcohol and Drug Outcome Measure (ADOM), a brief 18-item, two part, outcome monitoring instrument designed for routine use with clients in the New Zealand Alcohol and Other Drug (AOD) treatment sector. The development of the ADOM was informed by an expert panel of AOD clinicians (n = 6), key informant interviews (n = 14) and a pilot with AOD treatment clients and their respective clinicians (n = 25). The psychometric properties of the ADOM were tested with clients (n = 63) across a range of AOD treatment services. Testing involved clinicians administering the ADOM at treatment admission, one-to-seven days post-admission, and four-to-six weeks post-admission. Analyses of the test-retest reliability, concurrent validity and sensitivity to change of Part A of the ADOM, covering type and frequency of substance use, consistently produced excellent results. Comparable results for Part B of the instrument, covering associated psychosocial issues, were generally satisfactory. The ADOM has the potential to be used as a core AOD outcomes monitoring instrument., Internationally, there is an increasing call for the implementation of routine outcome monitoring during alcohol and other drug (AOD) treatment provision (Lawrinson, Roche, & Copeland, 2009; McLellan, Mckay, Forman, Cacciola, [...]

Published
2010

24. Measuring outcome in professional practice: considerations in selecting and using brief outcome instruments

Author

Lambert, Michael J. and Hawkins, Eric J.

Subjects
Patient monitoring equipment -- Evaluation, Psychotherapy -- Practice, Psychology and mental health
Abstract

Despite external pressures (e.g., quality assurance, therapist accountability) to measure outcome in psychotherapy, less than a third of clinicians choose to monitor outcome. A growing body of evidence suggests that monitoring patient progress can enhance patient outcome, particularly for patients who are at risk of not responding to treatment. To facilitate the adoption of routine assessment of patient outcome, recommendations for selecting an appropriate outcome instrument are suggested. In addition, procedures for implementing routine assessment of outcome and the use of outcome results are discussed.

Published
2004

25. Researchers from University Hospital Virgen Rocio Describe Findings in Type 1 Diabetes (Effectiveness and Safety of Insulin Glargine 300 U/ml In Comparison With Insulin Degludec 100 U/ml Evaluated With Continuous Glucose Monitoring In Adults ...)

Subjects
Medical research -- Analysis -- Reports -- Safety and security measures, Medicine, Experimental -- Analysis -- Reports -- Safety and security measures, Dextrose -- Safety and security measures -- Analysis -- Reports, Insulin glargine -- Evaluation, Type 1 diabetes -- Reports -- Analysis -- Safety and security measures, Insulin -- Evaluation, Patient monitoring equipment -- Evaluation, Glucose -- Safety and security measures -- Analysis -- Reports, Adults -- Analysis -- Safety and security measures -- Reports, Blood sugar monitoring -- Reports -- Analysis -- Safety and security measures, Health
Abstract

2021 NOV 1 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Trials Week -- Research findings on Nutritional and Metabolic Diseases and Conditions - Type 1 Diabetes are [...]

Published
2021

26. Combining rapid response with monitoring

Author

Michaels, Damon R., Nelson, Donna, Card, Elizabet, Jeskey, Mary, Lancaster, Leland J., and Berry, James M.

Subjects
Patient monitoring equipment -- Usage, Patient monitoring equipment -- Evaluation, Postoperative care -- Methods, Postoperative care -- Technology application, Technology application, Health
Abstract

A pilot study on the use of wireless monitoring systems to help care for postsurgical patients suggests that closer surveillance is required for this population as a large number of physiological disturbances go undetected. It is apparent that having a rapid response mechanism in place is not enough to detect subtle changes in the subjects.

Published
2009

29. Best Blood Pressure Monitors for $50 or Less

Subjects
Hypertension, Patient monitoring equipment -- Evaluation, General interest, News, opinion and commentary
Abstract

New York: Consumer Reports, Inc has issued the following news release: A good plan for those with high blood pressure includes regular exercise, a healthy diet, and (for some) medications. [...]

Published
2020

30. The problem with drinking: public attitudes, the severity continuum and treatment needs. A commentary on McFarlane and Tuffin (2010) and Pulford et al. (2010)

Author

Adamson, Simon J.

Subjects
Drug abuse -- Care and treatment, Treatment outcome -- Equipment and supplies, Alcoholism -- Care and treatment, Patient monitoring equipment -- Evaluation, Alcoholics -- Public opinion, Stigma (Social psychology) -- Analysis, Psychology and mental health
Abstract

This issue of NZJP contains two articles of interest to those concerned about the harms of alcohol and drug use in New Zealand. Currently New Zealand has the opportunity to [...]

Published
2010

31. Findings on Type 1 Diabetes Discussed by Investigators at Nemours Children's Hospital (Evaluation of Hemoglobin A1c Before and After Initiation of Continuous Glucose Monitoring In Children With Type 1 Diabetes Mellitus)

Subjects
Medical research -- Analysis, Medicine, Experimental -- Analysis, Pediatrics -- Research -- Analysis, Diabetes therapy -- Evaluation, Glycosylated hemoglobin -- Analysis -- Research, Type 1 diabetes -- Research, Patient monitoring equipment -- Evaluation, Blood sugar -- Research -- Analysis, Children -- Health aspects, Blood sugar monitoring -- Analysis -- Research, Health
Abstract

2021 APR 19 (NewsRx) -- By a News Reporter-Staff News Editor at Diabetes Week -- Investigators discuss new findings in Nutritional and Metabolic Diseases and Conditions - Type 1 Diabetes. [...]

Published
2021

32. Researchers at Percy Military Hospital Target Cardiac Output (Limitations of stroke volume estimation by non-invasive blood pressure monitoring in hypergravity)

Subjects
Physical fitness, Blood pressure measurement, Cardiac patients, Patient monitoring equipment -- Evaluation, Health
Abstract

2016 MAR 26 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Cardiac Output. According to news reporting originating [...]

Published
2016

33. Research Results from Lund University Update Knowledge of Health and Medicine (Continuous glucose monitoring for the prevention of morbidity and mortality in preterm infants)

Subjects
Blood -- Medical examination, Dextrose -- Research, Mortality -- Research, Patient monitoring equipment -- Evaluation, Glucose -- Research, Blood sugar monitoring -- Research, Infants (Premature) -- Patient outcomes, Health
Abstract

2021 JAN 8 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators publish new report on Health and Medicine. According to news reporting out [...]

Published
2021

35. New Cystic Fibrosis Findings Reported from Sydney Children's Hospital (Glucose abnormalities detected by continuous glucose monitoring are common in young children with Cystic Fibrosis)

Subjects
Cystic fibrosis -- Research, Glucose -- Reports -- Research, Blood glucose tests -- Reports -- Research, Patient monitoring equipment -- Evaluation, Health
Abstract

2020 OCT 2 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- New research on Lung Diseases and Conditions - Cystic Fibrosis is the subject [...]

Published
2020

38. FDA approves first continuous glucose monitoring system with a fully implantable glucose sensor and compatible mobile app for adults with diabetes

Subjects
United States. Food and Drug Administration, Prostheses and implants -- Evaluation, Glucose, Blood glucose tests, Type 2 diabetes, Sensors -- Evaluation, Medical testing products -- Evaluation, Patient monitoring equipment -- Evaluation, Diabetics, General interest, News, opinion and commentary
Abstract

SILVER SPRING: U.S. Food and Drug Administration has issued the following press release: - The U.S. Food and Drug Administration today approved the Eversense Continuous Glucose Monitoring (CGM) system for [...]

Published
2018

39. United States : FDA approves first continuous glucose monitoring system with a fully implantable glucose sensor and compatible mobile app for adults with diabetes

Subjects
United States. Food and Drug Administration, Prostheses and implants -- Evaluation, Glucose, Blood glucose tests, Type 2 diabetes, Sensors -- Evaluation, Medical testing products -- Evaluation, Patient monitoring equipment -- Evaluation, Diabetics, Business, international
Abstract

The U.S. Food and Drug Administration today approved the Eversense Continuous Glucose Monitoring (CGM) system for use in people 18 years of age and older with diabetes. This is the [...]

Published
2018

40. FDA APPROVES FIRST CONTINUOUS GLUCOSE MONITORING SYSTEM WITH A FULLY IMPLANTABLE GLUCOSE SENSOR AND COMPATIBLE MOBILE APP FOR ADULTS WITH DIABETES

Subjects
United States. Food and Drug Administration, Prostheses and implants -- Evaluation, Glucose, Blood glucose tests, Type 2 diabetes, Sensors -- Evaluation, Medical testing products -- Evaluation, Patient monitoring equipment -- Evaluation, Diabetics, News, opinion and commentary
Abstract

WASHINGTON -- The following information was released by the U.S. Food and Drug Administration (FDA): The U.S. Food and Drug Administration today approved the Eversense Continuous Glucose Monitoring (CGM) system [...]

Published
2018

41. FDA approves first continuous glucose monitoring system with a fully implantable glucose sensor and compatible mobile app for adults with diabetes

Subjects
United States. Food and Drug Administration, Dextrose, Prosthesis -- Evaluation, Implants, Artificial -- Evaluation, Sensors -- Evaluation, Medical testing products -- Evaluation, Patient monitoring equipment -- Evaluation, Glucose, Blood sugar monitoring, Type 2 diabetes, Diabetics, Business, News, opinion and commentary
Abstract

SILVER SPRING, Md., June 21, 2018 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved the Eversense Continuous Glucose Monitoring (CGM) system for use in people 18 years of [...]

Published
2018

42. How reliable is your wearable heart-rate monitor?

Subjects
Patient monitoring equipment -- Evaluation, Business, international
Abstract

Keele: Keele University of United Kingdom has issued the following news release: Fitbit, Garmin and other consumer heart-rate monitors are increasingly being used in clinical trials. The problem is, they're [...]

Published
2018

43. Non-Invasive Blood Glucose Monitor Approved By FDA, Could Help Diabetics Avoid Finger-pricks

Subjects
Blood glucose test, Sensors -- Evaluation, Medical testing products -- Evaluation, Blood glucose, Patient monitoring equipment -- Evaluation, Diabetics, Business, international, News, opinion and commentary
Abstract

Pricking fingers to draw out blood for testing their blood sugar, is a painful inconvenience that diabetics have to go through, throughout their lifetimes. But, there are many solutions being [...]

Published
2017

44. FDA approves glucose monitoring system that reduces need for fingerstick

Subjects
United States. Food and Drug Administration, Blood glucose test, Diabetes therapy -- Evaluation, Medical testing products -- Evaluation, Blood glucose, Patient monitoring equipment -- Evaluation, Diabetics, General interest, News, opinion and commentary
Abstract

Byline: AMY WALLACE Dec. 31 (UPI) -- The U.S. Food and Drug Administration Wednesday approved the first continuous glucose monitor that can be used by adults without calibration via a [...]

Published
2017

45. FDA APPROVES FIRST CONTINUOUS GLUCOSE MONITORING SYSTEM FOR ADULTS NOT REQUIRING BLOOD SAMPLE CALIBRATION

Subjects
United States. Food and Drug Administration, Glucose, Blood glucose test, Hypoglycemic agents, Type 2 diabetes -- Drug therapy, Diabetes therapy -- Evaluation, Medical testing products -- Evaluation, Patient monitoring equipment -- Evaluation, Adults, News, opinion and commentary
Abstract

WASHINGTON -- The following information was released by the U.S. Food and Drug Administration (FDA): The U.S. Food and Drug Administration today approved the FreeStyle Libre Flash Glucose Monitoring System, [...]

Published
2017

46. FDA approves first continuous glucose monitoring system for adults not requiring blood sample calibration

Subjects
United States. Food and Drug Administration, Diabetes therapy -- Evaluation, Dextrose, Medical testing products -- Evaluation, Hypoglycemic agents, Patient monitoring equipment -- Evaluation, Glucose, Adults, Blood sugar monitoring, Type 2 diabetes -- Drug therapy, Business, News, opinion and commentary
Abstract

SILVER SPRING, Md., Sept. 27, 2017 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved the FreeStyle Libre Flash Glucose Monitoring System, the first continuous glucose monitoring system that [...]

Published
2017

47. Intrapartum fetal heart rate monitoring in cases of congenital heart disease

Author

Ueda, Keiko, Ikeda, Tomoaki, Iwanaga, Naoko, Katsuragi, Shinj, Yamanaka, Kaoru, Neki, Reiko, Yoshimatsu, Jun, and Shiraishi, Isao

Subjects
Patient monitoring equipment -- Evaluation, Coronary heart disease, Congenital heart disease, Genetic disorders, Health
Abstract

To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.ajog.2009.03.015 Byline: Keiko Ueda (a), Tomoaki Ikeda (a), Naoko Iwanaga (a), Shinj Katsuragi (a), Kaoru Yamanaka (a), Reiko Neki (a), Jun Yoshimatsu (a), Isao Shiraishi (b) Keywords: congenital heart disease; fetal heart rate monitoring; variant FHR pattern Abstract: We evaluated the intrapartum fetal heart rate (FHR) patterns in fetuses with congenital heart disease (CHD). Author Affiliation: (a) Department of Perinatology, National Cardiovascular Center, Osaka, Japan (b) Department of Pediatric Cardiology, National Cardiovascular Center, Osaka, Japan Article History: Received 25 September 2008; Revised 4 January 2009; Accepted 6 March 2009 Article Note: (footnote) Authorship and contribution to the manuscript is limited to the 8 authors indicated. There was no outside funding or technical assistance with the production of this article., Cite this article as: Ueda K, Ikeda T, Iwanaga N, et al. Intrapartum fetal heart rate monitoring in cases of congenital heart disease. Am J Obstet Gynecol 2009;201:64.e1-6.

Published
2009

48. Switzerland : One of France's University Hospitals Adopts Masimo Radical-7, Including SpHb, PVI, and SET Pulse Oximetry

Subjects
Hospitals -- France, Hemoglobins, Patient monitoring equipment -- Evaluation, Anesthesia, Business, international
Abstract

Masimo announced today that Centre Hospitalier Universitaire (CHU) de Limoges, in Limoges, France has installed Masimo's Radical-7, including noninvasive, continuous hemoglobin (SpHb), Pleth Variability Index (PVI), and SET pulse oximetry [...]

Published
2016

49. One of France's University Hospitals Adopts Masimo Radical-7[R], Including SpHb[R], PVI[R], and SET[R] Pulse Oximetry

Subjects
Hospitals -- France, Hemoglobins, Patient monitoring equipment -- Evaluation, Anesthesia, Business, Business, international
Abstract

NEUCHTEL, Switzerland -- Masimo (NASDAQ: MASI) announced today that Centre Hospitalier Universitaire (CHU) de Limoges, in Limoges, France has installed Masimo's Radical-7[R], including noninvasive, continuous hemoglobin (SpHb([R])), Pleth Variability Index [...]

Published
2016

50. New Testing System Brings Beneficial Attention to Firm.

Author

PETTERSSON, EDVARD

Subjects
Medical test kit industry -- Evaluation, Diagnostic equipment (Medical) -- Evaluation, Medical equipment and supplies industry -- Evaluation, Patient monitoring equipment -- Evaluation, Securities dealers -- Evaluation, Securities industry -- Evaluation, Diagnostic Products Corp. -- Evaluation, SG Cowen Securities Corp. -- Evaluation, Securities industry
Abstract

FOR small-and mid-cap companies that have only a few analysts following their stock, an unequivocal endorsement by a major brokerage can make a huge difference. That's what happened with Los [...]

Published
2000

Catalog

Books, media, physical & digital resources
See catalog results